{"product_id":"2022-global-immunoassay-analyzers-and-reagents-usa-europe-japan-supplier-shares-and-competitive-analysis-volume-and-sales-segment-forecasts-for-100-abused-drugs-cancer-diagnostic-endocrine-function-immunoproteins-tdms-and-special-chemistry-tes","title":"2022 Global Immunoassay Analyzers and Reagents - USA, Europe, Japan - Supplier Shares and Competitive Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tes","description":"\u003cp\u003e2022 Global Immunoassay Analyzers and Reagents - USA, Europe, Japan - Supplier Shares and Competitive Analysis, Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer Diagnostic, Endocrine Function, Immunoproteins, TDMs, and Special Chemistry Tests Performed in Hospitals, Commercial\/Private Labs and POC Locations - Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers\u003c\/p\u003e \n\n\u003cp\u003eLeadingMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging in the immunoassay market during the next five years. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.\u003c\/p\u003e\n\n\u003cp\u003eThe report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.\u003c\/p\u003e\n\n\u003cp\u003eRationale\u003c\/p\u003e\n\n\u003cp\u003eThe immunoassay market is undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.\u003c\/p\u003e\n\n\u003cp\u003eWorldwide Market Overview\u003c\/p\u003e\n\n\u003cp\u003eEstimates of facilities performing clinical chemistry and immunoassay tests by country.\u003c\/p\u003e\n\n\u003cp\u003eTest volume and sales projections by country.\u003c\/p\u003e\n\n\u003cp\u003eStrategic Recommendations\u003c\/p\u003e\n\n\u003cp\u003eNew product development opportunities with significant market appeal.\u003c\/p\u003e\n\n\u003cp\u003eAlternative market penetration strategies.\u003c\/p\u003e\n\n\u003cp\u003ePotential market entry barriers and risks.\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Assessments\u003c\/p\u003e\n\n\u003cp\u003eStrategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R\u0026amp;D.\u003c\/p\u003e\n\n\u003cp\u003eThe companies analyzed in the report include Abbott Laboratories, Agilent Technologies, Beckman Coulter\/Danaher, bioMerieux, Bio-Rad, DiaSorin, Eiken Chemical, Fujifilm, Fujirebio, Grifols, Instrumentation Laboratory\/Werfen, Kyowa Medex, OrthoQuidel, PerkinElmer, Quest Diagnostics, Roche, Siemens Healthineers, Sysmex, Thermo Fisher, and Tosoh.\u003c\/p\u003e\n\n\u003cp\u003eClinical Chemistry\u003c\/p\u003e\n\n\u003cp\u003eAlbumin, Alkaline Phosphatase, ALT\/SGPT, Ammonia, Amylase, AST\/SGOT, Bilirubin, Total, BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide\/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.\u003c\/p\u003e\n\n\u003cp\u003eTherapeutic Drug Monitoring (TDM)\u003c\/p\u003e\n\n\u003cp\u003eAmikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA\/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.\u003c\/p\u003e\n\n\u003cp\u003eEndocrine Function\u003c\/p\u003e\n\n\u003cp\u003eCortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH\/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH.\u003c\/p\u003e\n\n\u003cp\u003eTumor Markers and Special Chemistry\u003c\/p\u003e\n\n\u003cp\u003eAFP, CA 15-3\/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12.\u003c\/p\u003e\n\n\u003cp\u003eImmunoproteins\u003c\/p\u003e\n\n\u003cp\u003eC3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM, Immunofixation, Prealbumin, Protein Electrophoresis.\u003c\/p\u003e\n\n\u003cp\u003eDrugs of Abuse\u003c\/p\u003e\n\n\u003cp\u003eAmphetamines, Barbiturates, Benzodiazepines, Cannabinoids\/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants.\u003c\/p\u003e\n\n\u003cp\u003eGeographic Coverage\u003c\/p\u003e\n\n\u003cp\u003eFrance, Germany, Italy, Japan, Spain, UK, US\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation Analysis\u003c\/p\u003e\n\n\u003cp\u003eComprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers, by country.\u003c\/p\u003e\n\n\u003cp\u003eTest volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, by country and market segment: Hospitals, Commercial\/Private Laboratories, Physician Offices\/Group Practices, Ambulatory Care Centers\u003c\/p\u003e\n\n\u003cp\u003eCurrent and Emerging Products\u003c\/p\u003e\n\n\u003cp\u003eAnalysis of current and emerging clinical chemistry and immunoassay tests.\u003c\/p\u003e\n\n\u003cp\u003eReview of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume\/POC analyzers.\u003c\/p\u003e\n\n\u003cp\u003eTechnology Review\u003c\/p\u003e\n\n\u003cp\u003eAssessment of current and emerging technologies, and their potential market applications.\u003c\/p\u003e\n\n\u003cp\u003eComprehensive lists of companies developing or marketing new technologies and products by test.\u003c\/p\u003e\n\n\n\n\u003cp\u003ePlease note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"November, 2022 \/ - \/ MCW16233753","offer_id":47650822914354,"sku":null,"price":17400.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/2022-global-immunoassay-analyzers-and-reagents-usa-europe-japan-supplier-shares-and-competitive-analysis-volume-and-sales-segment-forecasts-for-100-abused-drugs-cancer-diagnostic-endocrine-function-immunoproteins-tdms-and-special-chemistry-tes","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}